PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia Journal Article


Authors: Gu, Z.; Churchman, M. L.; Roberts, K. G.; Moore, I.; Zhou, X.; Nakitandwe, J.; Hagiwara, K.; Pelletier, S.; Gingras, S.; Berns, H.; Payne-Turner, D.; Hill, A.; Iacobucci, I.; Shi, L.; Pounds, S.; Cheng, C.; Pei, D.; Qu, C.; Newman, S.; Devidas, M.; Dai, Y.; Reshmi, S. C.; Gastier-Foster, J.; Raetz, E. A.; Borowitz, M. J.; Wood, B. L.; Carroll, W. L.; Zweidler-McKay, P. A.; Rabin, K. R.; Mattano, L. A.; Maloney, K. W.; Rambaldi, A.; Spinelli, O.; Radich, J. P.; Minden, M. D.; Rowe, J. M.; Luger, S.; Litzow, M. R.; Tallman, M. S.; Racevskis, J.; Zhang, Y.; Bhatia, R.; Kohlschmidt, J.; Mrózek, K.; Bloomfield, C. D.; Stock, W.; Kornblau, S.; Kantarjian, H. M.; Konopleva, M.; Evans, W. E.; Jeha, S.; Pui, C. H.; Yang, J.; Paietta, E.; Downing, J. R.; Relling, M. V.; Zhang, J.; Loh, M. L.; Hunger, S. P.; Mullighan, C. G.
Article Title: PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
Abstract: Recent genomic studies have identified chromosomal rearrangements defining new subtypes of B-progenitor acute lymphoblastic leukemia (B-ALL), however many cases lack a known initiating genetic alteration. Using integrated genomic analysis of 1,988 childhood and adult cases, we describe a revised taxonomy of B-ALL incorporating 23 subtypes defined by chromosomal rearrangements, sequence mutations or heterogeneous genomic alterations, many of which show marked variation in prevalence according to age. Two subtypes have frequent alterations of the B lymphoid transcription-factor gene PAX5. One, PAX5alt (7.4%), has diverse PAX5 alterations (rearrangements, intragenic amplifications or mutations); a second subtype is defined by PAX5 p.Pro80Arg and biallelic PAX5 alterations. We show that p.Pro80Arg impairs B lymphoid development and promotes the development of B-ALL with biallelic Pax5 alteration in vivo. These results demonstrate the utility of transcriptome sequencing to classify B-ALL and reinforce the central role of PAX5 as a checkpoint in B lymphoid maturation and leukemogenesis. © 2019, The Author(s), under exclusive licence to Springer Nature Limited.
Journal Title: Nature Genetics
Volume: 51
Issue: 2
ISSN: 1061-4036
Publisher: Nature Publishing Group  
Date Published: 2019-02-01
Start Page: 296
End Page: 307
Language: English
DOI: 10.1038/s41588-018-0315-5
PUBMED: 30643249
PROVIDER: scopus
PMCID: PMC6525306
DOI/URL:
Notes: Article -- Export Date: 1 March 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Stuart Tallman
    649 Tallman
  2. Yanming Zhang
    199 Zhang